We are live on ! Find out more
CA

Clearstead Advisors Portfolio holdings

AUM $10.6B
1-Year Est. Return 24.87%
This Fund
S&P 500
This Quarter Est. Return
+2.37%
1 Year Est. Return
+24.87%
3 Year Est. Return
+71.42%
5 Year Est. Return
+80.33%
10 Year Est. Return
AUM
$7.93B
AUM Growth
+$314M
Cap. Flow
+$948M
Cap. Flow %
11.95%
Top 10 Hldgs %
31.01%
Holding
3,334
New
245
Increased
1,176
Reduced
923
Closed
594

Sector Composition

Rank Sector Weight
1 Technology 12.05%
2 Financials 6.74%
3 Industrials 4.89%
4 Healthcare 3.63%
5 Consumer Discretionary 3.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLNE icon
2626
Clean Energy Fuels
CLNE
$346M
$42 ﹤0.01%
20
NSSC icon
2627
Napco Security Technologies
NSSC
$1.48B
$42 ﹤0.01%
1
-14
-93% -$589
BCBP icon
2628
BCB Bancorp
BCBP
$161M
$41 ﹤0.01%
5
-29
-85% -$234
CZNC icon
2629
Citizens & Northern Corp
CZNC
$455M
$41 ﹤0.01%
2
-23
-92% -$459
XPRO icon
2630
Expro Ltd
XPRO
$1.91B
$41 ﹤0.01%
3
-312
-99% -$4.21K
PLGO
2631
Pelagos Insurance Capital
PLGO
$2.14B
$40 ﹤0.01%
2
-126
-98% -$2.35K
LXEO icon
2632
Lexeo Therapeutics
LXEO
$378M
$40 ﹤0.01%
4
-300
-99% -$2.74K
ANGI icon
2633
Angi Inc
ANGI
$196M
$39 ﹤0.01%
3
-399
-99% -$5.14K
RMAX icon
2634
RE/MAX Holdings
RMAX
$242M
$38 ﹤0.01%
5
-152
-97% -$1.23K
FSUN
2635
FirstSun Capital Bancorp
FSUN
$1.96B
$38 ﹤0.01%
1
-114
-99% -$4.15K
FLOC
2636
Flowco Holdings
FLOC
$911M
$38 ﹤0.01%
+2
New +$33
ZBIO
2637
Zenas BioPharma
ZBIO
$2.05B
$37 ﹤0.01%
1
-22
-96% -$724
BWB icon
2638
Bridgewater Bancshares
BWB
$603M
$36 ﹤0.01%
2
-36
-95% -$625
COGT icon
2639
Cogent Biosciences
COGT
$7.24B
$36 ﹤0.01%
1
-2
-67% -$56
OOMA icon
2640
Ooma
OOMA
$604M
$36 ﹤0.01%
+3
New +$34
PRAA icon
2641
PRA Group
PRAA
$755M
$36 ﹤0.01%
2
-60,005
-100% -$934K
LTC
2642
LTC Properties
LTC
$2.15B
$35 ﹤0.01%
1
-113
-99% -$3.98K
AGL icon
2643
Agilon Health
AGL
$1.6B
$34 ﹤0.01%
+2
New +$39
CRNC icon
2644
Cerence
CRNC
$413M
$33 ﹤0.01%
3
-171
-98% -$1.88K
FRBA icon
2645
First Bank
FRBA
$454M
$33 ﹤0.01%
2
-12
-86% -$192
AROW icon
2646
Arrow Financial
AROW
$652M
$32 ﹤0.01%
+1
New +$30
AUPH icon
2647
Aurinia Pharmaceuticals
AUPH
$2.11B
$32 ﹤0.01%
2
-385
-99% -$5.46K
BCRX icon
2648
BioCryst Pharmaceuticals
BCRX
$2.4B
$32 ﹤0.01%
+4
New +$29
DENN
2649
DELISTED
Denny's
DENN
$32 ﹤0.01%
5
-1,207
-100% -$6.84K
FSFG
2650
DELISTED
First Savings Financial Group
FSFG
$32 ﹤0.01%
1
-5
-83% -$155

Similar funds

Clearstead Advisors's Q4 2025 Portfolio in Review

As of Q4 2025, Clearstead Advisors held 3,334 positions worth $7.93B, up 4.1% from $7.62B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Clearstead Advisors deployed $948M of net new capital in Q4 2025, opening 245 new positions and adding to 1,176 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 1,170,336 shares worth $734M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Invesco BulletShares 2027 Corporate Bond ETF, an estimated $29.8M trimmed.

  • Clearstead Advisors's largest Q4 2025 buy was Vanguard S&P 500 ETF: 1,170,336 shares worth $734M.
  • Clearstead Advisors added most to Invesco BulletShares 2033 Corporate Bond ETF in Q4 2025, an estimated $32.2M increase.
  • Clearstead Advisors's biggest Q4 2025 reduction was Invesco BulletShares 2027 Corporate Bond ETF, cutting an estimated $29.8M.
  • Clearstead Advisors fully exited Kellanova in Q4 2025, selling an estimated $2.05M.
  • Clearstead Advisors's ten largest holdings make up 31% of its $7.93B portfolio in Q4 2025.
  • Clearstead Advisors opened 245 new positions and closed 594 in Q4 2025.
  • Clearstead Advisors's portfolio value rose 4.1% quarter-over-quarter to $7.93B.

Based on Clearstead Advisors's 13F filing for Q4 2025, filed 9 Feb 2026.